Research Excellence Award
| Jon Jyoti Sahariah | |
|---|---|
| Affiliation | Researcher in Drug Discovery and Medicinal Chemistry |
| Country | India |
| ORCID | 0000-0002-3632-2939 |
| Google Scholar | Profile |
| Citations | 216 |
| h-index | 7 |
| Ducuments | 32 |
| Research Area | Drug Discovery, Medicinal Chemistry, Pharmaceutical Sciences |
| Event | Indian Scientist Awards |
Jon Jyoti Sahariah is an emerging researcher in the field of drug discovery and medicinal chemistry. His scientific work focuses on the development of novel therapeutic compounds, pharmaceutical research, medicinal chemistry, and bioactive molecules for the treatment of various diseases.
Through interdisciplinary research and scientific collaboration, he has contributed to the advancement of pharmaceutical sciences, particularly in areas related to drug development, natural bioactive compounds, and modern medicinal chemistry approaches.
Abstract
Jon Jyoti Sahariah has contributed to pharmaceutical and medicinal chemistry research through studies focused on drug discovery, bioactive compounds, and therapeutic development. His research activities emphasize identifying novel compounds with potential biological applications and advancing scientific knowledge in pharmaceutical sciences.
Keywords
Drug Discovery, Medicinal Chemistry, Pharmaceutical Sciences, Bioactive Compounds, Therapeutic Agents, Pharmacology, Natural Products, Drug Development.
Introduction
Drug discovery and medicinal chemistry are fundamental disciplines in the development of modern therapeutics. Researchers in these fields play a critical role in identifying and optimizing compounds capable of addressing major health challenges.
Research Profile
Sahariah has established a research profile centered on medicinal chemistry and pharmaceutical sciences. His work integrates chemical synthesis, biological evaluation, and drug discovery methodologies to support the development of effective therapeutic candidates.
Research Work
The primary focus of Sahariah’s research includes medicinal chemistry, bioactive natural products, drug discovery, therapeutic development, and pharmaceutical research. His studies explore potential drug candidates and their biological activities with the goal of contributing to future healthcare solutions.
Selected Publications
- Cancer Chemotherapy via Natural Bioactive Compounds.
- From Bench to Bedside: Advancing Liposomal Doxorubicin for Targeted Cancer Therapy.
- Research Contributions in Drug Discovery and Pharmaceutical Sciences.
Technical Skills
- Medicinal Chemistry.
- Drug Discovery Research.
- Pharmaceutical Sciences
Research Impact
Sahariah’s research activities contribute to the advancement of medicinal chemistry and drug discovery. His scholarly publications and collaborative studies support ongoing efforts toward the development of innovative therapeutic solutions and pharmaceutical technologies.
Award Suitability
Jon Jyoti Sahariah demonstrates notable contributions in drug discovery and medicinal chemistry through research publications, scientific collaborations, and pharmaceutical investigations. These accomplishments support his recognition for the Women Researcher Award nomination profile format and research excellence evaluation.
Conclusion
Jon Jyoti Sahariah continues to contribute to pharmaceutical sciences through research in medicinal chemistry and drug discovery. His scientific efforts reflect a commitment to advancing healthcare research and supporting the development of innovative therapeutic strategies.
External Links
References
-
- M.Z. Ahmad, G. Mustafa, B.A. Abdel-Wahab, K. Pathak, A. Das, J.J. Sahariah, et al. From Bench to Bedside: Advancing Liposomal Doxorubicin for Targeted Cancer Therapy. Results in Surfaces and Interfaces, 19, 100473, 2025.
DOI: 10.1016/j.rsurfi.2025.100473
https://doi.org/10.1016/j.rsurfi.2025.100473 - P.P. Borthakur, A. Das, J.J. Sahariah, P. Pramanik, E. Baruah, K. Pathak. Revolutionizing Patient Care: 3D Printing for Customized Medical Devices and Therapeutics. Biomedical Materials & Devices, 4(2), 1275–1302, 2026.
DOI: 10.1007/s44174-025-00311-7
https://doi.org/10.1007/s44174-025-00311-7
- M.Z. Ahmad, G. Mustafa, B.A. Abdel-Wahab, K. Pathak, A. Das, J.J. Sahariah, et al. From Bench to Bedside: Advancing Liposomal Doxorubicin for Targeted Cancer Therapy. Results in Surfaces and Interfaces, 19, 100473, 2025.